Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02296684
Title Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

hypopharynx cancer

laryngeal squamous cell carcinoma

oropharynx cancer

head and neck squamous cell carcinoma

oral squamous cell carcinoma

Therapies

Pembrolizumab

Cisplatin

Age Groups: adult
Covered Countries USA


No variant requirements are available.